Transaction in Own Shares

NatWest Group plc
15 March 2024
 

NatWest Group plc

15 March 2024


Transaction in Own Shares

NatWest Group plc (the 'Company') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS') across two transactions, Transaction 1 and Transaction 2 (together the 'Transactions').









The purchases form part of the Company's existing share buyback programmes, with Transaction 1 purchases effected pursuant to the instructions issued by the Company to UBS on 28 July 2023, as announced on 31 July 2023 and Transaction 2 purchases effected pursuant to the instructions issued by the Company to UBS on 16 February 2024, as announced on 19 February 2024.









Aggregated information relating to the Transactions is set out in the tables below.









Transaction 1:

 













Date of purchase

Number of Ordinary Shares purchased

Highest price paid: (GBp)

Lowest price paid: (GBp)

Volume  weighted average price paid per share (GBp)

Venue


15 March 2024

0

0.00

0.00

0.0000

LSE


15 March 2024

0

0.00

0.00

0.0000

CHIX


15 March 2024

0

0.00

0.00

0.0000

BATE









Transaction 2:

 













Date of purchase

Number of Ordinary Shares purchased

Highest price paid: (GBp)

Lowest price paid: (GBp)

Volume  weighted average price paid per share (GBp)

Venue


15 March 2024

5,000,000

243.50

240.30

242.0368

LSE


15 March 2024

1,943,984

243.40

240.30

242.2668

CHIX


15 March 2024

4,000,000

243.40

240.30

242.2533

BATE









* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share









The Company intends to cancel all of the Ordinary Shares repurchased under the Transactions. Following the settlement of the transactions, the Company will hold 151,039,340 Ordinary Shares in treasury and have 8,752,153,451 Ordinary Shares in issue (excluding treasury shares).


http://www.rns-pdf.londonstockexchange.com/rns/1245H_1-2024-3-15.pdf









Further information:








Investor Relations







+ 44 (0)207 672 1758














Media Relations







+44 (0)131 523 4205














Legal Entity Identifier: 2138005O9XJIJN4JPN90








Details of the Transactions

 





In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programmes relating to the Transactions available here: [RNS team to insert link]


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings